<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The efficacy and tolerability of high-dose neurotrophic drug cerebrolysin was studied in 20 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> diagnosed by criteria NINDS-AIREN and <z:chebi fb="4" ids="38624">DSM</z:chebi>-IV </plain></SENT>
<SENT sid="1" pm="."><plain>The drug was well tolerated, affected positively cognitive function, especially neurodynamic processes </plain></SENT>
<SENT sid="2" pm="."><plain>EEG featured after treatment intensification of rapid rhythms power and a decrease in delta-activity spectrum </plain></SENT>
<SENT sid="3" pm="."><plain>The highest effect of cerebrolysin was achieved in patients with mild <z:hpo ids='HP_0100543'>cognitive defects</z:hpo> </plain></SENT>
</text></document>